Fed-fasted BE studies using different polymorphs [Regulatives / Guidelines]

posted by Ohlbe – France, 2009-08-31 03:34 (6138 d 10:47 ago) – Posting: # 4137
Views: 6,505

Dear London and Helmut,

❝ ❝ [...] the fasted study will be repeated.


❝ Danger! I would say that the part about mandatory submission of all studies from the 2008 BE drafted guideline will survive and make it to the final version.


Independently of the guideline, for EU submissions Annex I to Directive 2001/83/EC, as amended by Directive 2003/63/EC, requires that all clinical trials conducted on the product be submitted, whether positive or negative.

A lot of fuss has been made about this paragraph in the draft EU guideline. There was nothing new in it: this requirement is in place since at least 1975 (Annex to Directive 75/318/EC).

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
143 visitors (0 registered, 143 guests [including 42 identified bots]).
Forum time: 14:22 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5